Studies targeting KLRG1 have shown that KLRG1 not only serves as a marker of T-cell senescence [65] but also increases with disease severity in autoimmune, viral infections and cancer, and can serve as a biomarker for assessing disease progression and prognosis [16, 27, 80, 92, 99]. The gene discussed is KLRG1; the disease is cancer.